# Robustness Results Interpretation Round 1

## Scope

This review interprets the actual aggregate robustness outputs generated in:

- `/Users/joaokasprowicz/.codex/worktrees/9965/research-agent/projects/lab-phenotyping/outputs/robustness/`
- `/Users/joaokasprowicz/.codex/worktrees/9965/research-agent/projects/lab-phenotyping/tables/`
- `/Users/joaokasprowicz/.codex/worktrees/9965/research-agent/projects/lab-phenotyping/supplementary/`

The focus is limited to four high-priority scientific risks:

1. no-age clustering sensitivity
2. repeated encounters
3. testing-intensity bias introduced by `n_exames >= 6`
4. whether the current phenotypes remain scientifically defensible

This is an interpretation review only. The manuscript was not modified in this round.

## Executive Interpretation

The new robustness outputs materially strengthen the paper, but in a specific way: they support the current clusters as exploratory laboratory phenotypes, not as stable or broadly generalizable clinical subgroups. The no-age sensitivity analysis is the most reassuring result. Removing `idade` reduces geometric separation, but the qualitative phenotype structure persists, including the inflammatory-renal pattern. This argues against age being the sole engine of the clustering solution.

At the same time, the repeated-encounter and testing-intensity analyses show that phenotype prevalence is sensitive to design choices. Recurrent patients inflate the relative frequency of the two more abnormal phenotypes, and the `n_exames >= 6` rule retains only about one third of candidate encounters. These findings do not invalidate the study, but they do require conservative framing. The cohort should be described as a selected multimarker-rich encounter cohort rather than a general emergency population.

## 1. No-Age Clustering Sensitivity

## Main findings

From `no_age_silhouette_scores.csv`:

- `k=3` without age: silhouette `0.2427`
- `k=2` without age: silhouette `0.2764`
- `k=4-6` without age: progressively lower silhouette values

From the current manuscript and prior results:

- original `k=3` solution with age: silhouette `0.29`

From `no_age_cluster_distribution.csv`:

- no-age cluster 0: `59.1%`
- no-age cluster 1: `20.9%`
- no-age cluster 2: `20.1%`

From `no_age_cluster_comparison.csv` and `no_age_cluster_profile_summary.csv`:

- no-age cluster 1 maps predominantly to current cluster 0 and retains the strongest inflammatory-renal signature:
  - median age `68.7`
  - median PCR `31.42`
  - median creatinine `1.48`
  - median urea `65.82`
- no-age cluster 2 maps predominantly to current cluster 1 and retains the hepatic-like pattern:
  - median TGO `61.4`
  - median TGP `50.9`
  - lower leukocytes and platelets
- no-age cluster 0 maps predominantly to current cluster 2 and retains the basal-like pattern:
  - lower creatinine and urea
  - lower transaminases
  - lower inflammatory burden than the inflammatory-renal cluster

## Scientific interpretation

Age is clearly a structural contributor to the clustering solution. The drop in silhouette from about `0.29` to `0.24` indicates that age improves separation and contributes nontrivially to latent geometry. That point should not be minimized.

However, the more important scientific result is that the cluster identities remain recognizable without age. The inflammatory-renal phenotype does not collapse after removing `idade`; it remains the cluster with the highest creatinine, urea, and PCR values, and it also remains the oldest group. This suggests that age is associated with the phenotype, but does not fully manufacture it.

The same is true, to a lesser degree, for the hepatic-like phenotype. It remains characterized by relatively higher transaminases and lower leukocyte and platelet counts, which supports the interpretation that this cluster also reflects a real laboratory pattern rather than a purely age-defined partition.

## What this strengthens

- The current phenotypes are not reducible to age alone.
- The inflammatory-renal phenotype remains qualitatively stable after age removal.
- The study now has a defensible response to the likely reviewer criticism that clustering is merely an age partition.

## What remains weak

- Age still appears to be an important organizing variable.
- The no-age analysis supports robustness of phenotype interpretation, but not full stability.
- The fact that `k=2` has the highest silhouette without age raises the possibility that the three-cluster solution is partly driven by interpretive preference rather than purely geometric optimality.

## Bottom line

The no-age sensitivity analysis improves scientific defensibility substantially. It supports the claim that the reported clusters are exploratory multimarker phenotypes with age-associated structure, rather than clusters created solely by chronological age.

## 2. Repeated Encounter Analysis

## Main findings

From `repeated_encounter_summary.csv`:

- total encounters: `120216`
- unique patients: `81629`
- repeated patients: `21295`
- repeated encounters beyond first: `38587`

From `encounters_per_patient_distribution.csv`:

- one encounter: `73.9%` of patients
- two encounters: `15.5%`
- three to five encounters: `9.3%`
- six to ten encounters: `1.1%`
- more than ten encounters: `0.15%`

From `cluster_prevalence_all_vs_first_encounter.csv`:

- all encounters:
  - cluster 0: `22.1%`
  - cluster 1: `19.0%`
  - cluster 2: `58.9%`
- first encounter only:
  - cluster 0: `18.9%`
  - cluster 1: `17.3%`
  - cluster 2: `63.9%`

## Scientific interpretation

Repeated encounters are not a trivial feature of this dataset. More than one quarter of patients contributed more than one encounter, and there are `38,587` encounters beyond the first. This is large enough to affect prevalence estimates materially.

The first-encounter sensitivity analysis confirms that it does. When repeated encounters are removed, the basal phenotype becomes more prevalent, rising from `58.9%` to `63.9%`, while the inflammatory-renal and hepatic-like phenotypes both become less prevalent. This pattern is clinically plausible: patients with more complex or recurrent care trajectories may be overrepresented in the more abnormal laboratory phenotypes.

This does not invalidate the phenotypes themselves. The direction of change affects composition and prevalence more than phenotype identity. But it does mean that cluster frequencies should be interpreted as encounter-level frequencies unless first-encounter-only estimates are also reported.

## What this strengthens

- The study now has direct evidence that repeated encounters alter prevalence, rather than leaving that issue purely speculative.
- The analysis supports a more honest and defensible statement about the unit of analysis: encounters, not patients.

## What this weakens

- The headline prevalence of the abnormal phenotypes is inflated relative to a patient-first view.
- Any language implying patient-level phenotype prevalence is currently too strong unless explicitly qualified.
- Reviewers may argue that recurrent-utilizer biology and recurrent-utilizer healthcare behavior are partially entangled in the present results.

## Minimal defensible conclusion

The phenotype structure remains usable, but the prevalence estimates are encounter-weighted and sensitive to recurrence. The manuscript should eventually report this explicitly, ideally in the main text or at least in the supplement.

## 3. Testing-Intensity Bias from `n_exames >= 6`

## Main findings

From `testing_intensity_filter_summary.csv`:

- encounters before filter: `120036`
- encounters after filter: `41084`
- excluded encounters: `78952`
- retained percentage: `34.2%`

From `testing_intensity_distribution.csv`:

- `1-3` exams: `50.4%`
- `4-5` exams: `15.3%`
- `6-7` exams: `9.5%`
- `8-10` exams: `12.9%`
- `>10` exams: `11.8%`

From `testing_intensity_group_characteristics.csv`:

- pre-filter median `n_exames`: `3`
- post-filter median `n_exames`: `9`
- pre-filter median age: `49.5`
- post-filter median age: `49.5`

## Important caution

Some percentages in `testing_intensity_group_characteristics.csv` appear internally inconsistent with the final cohort table, especially the sex and care-setting proportions. Those exact percentages should not be cited without rechecking the derivation. The retained-count analysis, however, is straightforward and still informative.

## Scientific interpretation

This is the most important remaining limitation for generalizability. The `n_exames >= 6` rule is not a mild completeness filter. It is a strong cohort-selection step that retains roughly one third of candidate encounters and excludes the majority of lower-density laboratory encounters.

This means the analyzed cohort is best understood as a multimarker-rich subset of emergency-related laboratory encounters, not as a general emergency department population. That distinction matters because testing intensity is often related to clinical complexity, physician concern, workflow context, and patient trajectory. Even if the available group-level outputs do not yet fully quantify severity enrichment, the design makes some degree of enrichment highly likely.

The testing-intensity results therefore support a narrower but more scientifically defensible claim: the study identifies latent laboratory phenotypes among encounters with sufficient multimarker information, rather than among all emergency encounters.

## What this strengthens

- The paper can now frame its inclusion rule transparently and quantitatively.
- The study has a clearer scientific identity as a multimarker phenotyping analysis.

## What this weakens

- The current cohort is not representative of routine low-complexity encounters.
- Any broad claim about emergency-population phenotyping remains too strong.
- Reviewers may ask whether the clusters partly reflect clinician ordering behavior rather than only patient biology.

## Bottom line

The filter does not invalidate the study, but it changes the population being described. This is a major framing issue, not a fatal analytic flaw.

## 4. Are the Current Phenotypes Still Scientifically Defensible?

## Short answer

Yes, but specifically as exploratory laboratory phenotypes derived from a selected, multimarker-rich encounter cohort.

## Why they remain defensible

- The three clusters remain clinically interpretable.
- The inflammatory-renal phenotype persists after removing age.
- The hepatic-like phenotype also persists qualitatively.
- The basal phenotype remains the dominant cluster in both the original and no-age analyses.
- The UMAP and silhouette results together remain compatible with partial separation and continuous heterogeneity rather than arbitrary noise.

## Why they are still not stable clinical subgroups

- Separation is modest, not strong.
- Silhouette decreases meaningfully when age is removed.
- Cluster prevalence changes when repeated encounters are restricted to first encounters.
- The analytic sample is strongly shaped by the `n_exames >= 6` filter.
- There is still no external validation, outcome anchoring, or broader preprocessing sensitivity package beyond the minimal robustness set.

## Defensible claims now

- The data support the existence of reproducible exploratory laboratory patterns with inflammatory-renal, hepatic-like, and basal characteristics.
- These phenotypes appear only weakly related to care-setting categories in the current analysis.
- The latent structure is compatible with biological heterogeneity present in acute-care laboratory data.

## Claims that remain too strong

- The clusters represent stable clinical subphenotypes.
- The results are broadly generalizable to the emergency population as a whole.
- The phenotypes are independent of age or recurrence effects.
- The clusters directly reflect disease mechanisms rather than a mixture of biology, care processes, and cohort selection.

## What Strengthens the Paper

- The no-age sensitivity result is a meaningful scientific gain.
- The repeated-encounter analysis demonstrates transparency about a common EHR weakness.
- The testing-intensity analysis quantifies the selection process instead of leaving it implicit.
- The combined outputs make the current manuscript much more defensible as an exploratory phenotyping paper than it was before these robustness checks existed.

## What Weakens the Paper

- The `n_exames >= 6` filter remains a major selection mechanism.
- Encounter-level recurrence materially shifts prevalence.
- Age still contributes importantly to separation.
- Some auxiliary testing-intensity composition outputs appear to need validation before manuscript use.
- The study still lacks outcome linkage and external validation.

## Is the Paper Now Substantially More Defensible?

Yes. It is substantially more defensible than before, mainly because the most obvious reviewer objections are no longer entirely unanswered.

Before these outputs, concerns about age dominance, repeated encounters, and filter bias were largely inferential. Now they are quantified. The results do not eliminate those concerns, but they narrow them and make the manuscript easier to frame honestly. That is a meaningful improvement in publication readiness.

The appropriate publication stance is now:

- exploratory
- encounter-based
- multimarker-rich
- clinically interpretable
- not yet validated as stable patient-level subphenotypes

## Reviewer Criticisms That Remain Unresolved

### 1. Selection by testing intensity

The biggest unresolved concern is that the cohort is heavily selected by laboratory density. A reviewer may still argue that the clusters are partly phenotypes of test-ordering intensity or case complexity.

### 2. Lack of adult-only and pediatric-only sensitivity analyses

The main cohort includes both age groups, and although the no-age sensitivity helps, it does not replace age-stratified analyses. A reviewer may still ask whether pediatric physiology contributes to the observed geometry.

### 3. No external validation

The phenotypes remain internally plausible, but there is no replication in a separate cohort, time period, or institution.

### 4. Limited preprocessing robustness

The current robustness package is helpful, but still minimal. Reviewers could still ask how sensitive the solution is to imputation strategy, clipping, scaling choices, or alternate clustering algorithms.

### 5. Lack of clinical outcome anchoring

The phenotypes are biologically plausible, but not yet linked to admission, ICU transfer, mortality, or other downstream outcomes. This limits claims about clinical relevance.

## Recommended Use in the Next Manuscript Round

## Must be reflected eventually

- State clearly that robustness analyses show persistence of the inflammatory-renal phenotype after removing age.
- Report that repeated encounters alter prevalence, especially increasing the abnormal phenotypes in all-encounter analyses.
- Reframe the cohort as a selected multimarker-rich encounter cohort.

## Best moved to supplementary material

- detailed no-age cluster tables
- first-encounter vs all-encounter prevalence table
- testing-intensity distribution table

## Should not be overstated

- any claim of age independence
- any implication of patient-level prevalence without qualification
- any implication that the cohort represents the full emergency spectrum

## Final Judgment

The robustness results support keeping the paper alive and strengthening it, not downgrading it. The core phenotypes remain interpretable and scientifically plausible after the first meaningful sensitivity checks. The study is now substantially more defensible as an exploratory clinical laboratory phenotyping manuscript.

The remaining challenge is not whether there is a paper, but whether the paper is framed with enough restraint. If it is presented as an exploratory, multimarker-rich, encounter-based phenotyping study with transparent limitations, the current robustness results support submission after careful manuscript revision. If it is presented as a broadly generalizable or stable-subphenotype study, the remaining weaknesses will still be easy targets for peer review.
